CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial.
about
Atypical Parkinsonian syndromes: a general neurologist's perspective.Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.Emerging Diagnostic and Therapeutic Strategies for Tauopathies.Recognizing Atypical Parkinsonisms: "Red Flags" and Therapeutic Approaches.
P2860
CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CoQ10 in progressive supranucl ...... ontrolled, double-blind trial.
@en
type
label
CoQ10 in progressive supranucl ...... ontrolled, double-blind trial.
@en
prefLabel
CoQ10 in progressive supranucl ...... ontrolled, double-blind trial.
@en
P2093
P2860
P1476
CoQ10 in progressive supranucl ...... ontrolled, double-blind trial.
@en
P2093
David G Standaert
David K Simon
Diana Apetauerova
Robert W Hamill
Robin Ruthazer
Stephanie A Scala
Subash Pathak
Talene A Yacoubian
P2860
P356
10.1212/NXI.0000000000000266
P577
2016-08-02T00:00:00Z